Therapeutic Review
Expert advice on choosing and using ophthalmic medications. By Jessica Steen, OD
The Dorzolamide Diaries
Explore the use of CAIs as an off-label treatment or adjunct in the management of other conditions.
12/15/2024
Supporting Corneal Repair
Available adjuncts to standard therapy can enhance treatment in cases of erosion or dystrophy.
10/15/2024
All Roads Lead to Dry Eye
Glaucoma patients are even more likely to develop this condition.
09/15/2024
Heartfelt Insight
Be aware of the cardiopulmonary effects of beta blockers.
06/15/2024
Twin Tumor Therapies
Tivdak and Elahere are important advances for disease control in aggressive, often difficult-to-treat gynecological cancers.
04/15/2024
Common Threads
RNFL defects are an important clinical finding in glaucomatous optic neuropathy, but the diagnosis may not always be obvious.
02/15/2024
Ischemic Retinal Ordeal
Neovascular glaucoma requires prompt and aggressive management of IOP and VEGF production.
12/15/2023
Keep Count
Endothelial cell loss is a common source of worry in patients with both glaucoma and corneal disease.
10/11/2023
There and MAC Again
Optometrists need a roadmap when dealing with the potential spectrum of conditions these bacteria can cause.
08/15/2023
No Pressure, Really
Here’s how I found myself experiencing hypotony—and why this rare complication of intravitreal injection should be on our radar.
06/15/2023
Upcoming Events
January 14, 2025
From Comprehensive to Retina: Intelligently Advancing OCT
Location: Virtual
Presenters: Rishi P. Singh, MD, and Katherine Talcott, MD
Webinar: 8:00pm ET
Sponsored by Zeiss
May 2-3, 2025
New Technologies & Treatments in Eye Care and Intrepid Eye Society–Spring
Location: Hilton La Jolla Torrey Pines, La Jolla, California
Co-Chairs: Paul Karpecki, OD, Jake Lang, OD, and Selina McGee, OD
Earn LIVE COPE Credits* (Accreditation pending)
Job of the Week
